Publications by authors named "Kyle M Hurth"

Claim this Profile
A
A contemporary, multiinstitutional analysis of transcription factor lineage in pituitary adenomas: comparative study of neuroimaging, histopathology, and clinical outcomes.
Stephanie K Cheok, Jacob Ruzevick, Robert G Briggs, David J Cote, Ishan Shah, Kyle M Hurth

J Neurosurg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for cPLA2 activation in Alzheimer's Disease Synaptic Pathology.
Qiu-Lan Ma, Brandon Ebright, Boyang Li, Jing Li, Jasmin Galvan, Kyle M Hurth

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of plasma metagenomic sequencing in identification of Balamuthia mandrillaris encephalitis.
Sarah Y Edminster, Ryan W Rebbe, Christopher Khatchadourian, Kyle M Hurth, Anna J Mathew

Acta Neuropathol Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial meningioma: A review of recent and emerging data on the utility of preoperative imaging for management.
Bryce D Beutler, Jonathan Lee, Sarah Edminster, Priya Rajagopalan, Thomas G Clifford, Kyle M Hurth

J Neuroimaging· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Multimodal Management of an Aggressive Functional Gonadotropic Pituitary Macroadenoma.
Jeffrey J Feng, Sophie M Cannon, Stephanie K Cheok, Mark S Shiroishi, Kyle M Hurth

AACE Clin Case Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurotropism of SARS-CoV-2: A Pathological Examination of Neurosurgical Specimens.
Tatsuhiro Fujii, Robert C Rennert, Kyle M Hurth, Pamela M Ward, Mihaela Campan

Neurosurgery· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis.
Ben Yi Tew, Alex J Kalfa, Zeyi Yang, Kyle M Hurth, Thomas Simon

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case.
Axel H Schönthal, Steve Swenson, Phillip A Bonney, Naveed Wagle, Vincent F Simmon, Kyle M Hurth

J Neurosurg Case Lessons· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant.
Leila Darki, Arash Jalali-Sohi, Samuel Guzman, Anna J Mathew, Robert C Bucelli, Kyle M Hurth

Clin Neurol Neurosurg· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of neuroendocrine acquisition and biomarker expression between neuroendocrine and usual prostatic carcinoma.
Guang-Qian Xiao, Grant Ho, Catherine Suen, Kyle M Hurth

Prostate· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.
Axel H Schönthal, David M Peereboom, Naveed Wagle, Rose Lai, Anna J Mathew, Kyle M Hurth

Neurooncol Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZBTB16: A new biomarker for primitive neuroectodermal tumor element / Ewing sarcoma.
Guang-Qian Xiao, Andy E Sherrod, Kyle M Hurth

Pathol Res Pract· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Rathke's Cleft Cysts: Incidence and Surgical Management in a Tertiary Pituitary Center over 2 Decades.
Michelle A Wedemeyer, Michelle Lin, Vance L Fredrickson, Anush Arakelyan, Daniel Bradley, Kyle M Hurth

Oper Neurosurg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quadruple Neoplasms following Radiation Therapy for Congenital Bilateral Retinoblastoma.
Linda J Szymanski, Maria E Sibug Saber, Jonathan W Kim, John L Go, Gabriel Zada, Kyle M Hurth

Ocul Oncol Pathol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease.
Richard A Armstrong, Paul T Kotzbauer, Joel S Perlmutter, Meghan C Campbell, Kyle M Hurth

J Neural Transm (Vienna)· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent adult-onset hypophyseal Langerhans cell histiocytosis after radiotherapy: a case report.
Ryan K Funk, Daniel J Ferraro, Richard J Perrin, Kyle M Hurth, John J Stephens

J Med Case Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchial atresia.
Matthew G Gipson, Kristopher W Cummings, Kyle M Hurth

Radiographics· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling.
Kyle M Hurth, Mark J Nilges, Kathryn E Carlson, Anobel Tamrazi, R Linn Belford

Biochemistry· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate.
Anobel Tamrazi, Kathryn E Carlson, Jonathan R Daniels, Kyle M Hurth, John A Katzenellenbogen

Mol Endocrinol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis